Sanifoam Sunger Sanayi ve Ticaret AS (SANFM) fair value: what the stock is really worth
As of Oct 16, 2026: fair value of Sanifoam Sunger Sanayi ve Ticaret AS TRY 0.82, price TRY 4.18, upside -80.4%, quality 26 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 17, 2026.
How to read this chart
60‑month range 0.6444 TRY – 22.23 TRY · the 4.18 TRY price screens above the 0.8200 TRY fair value. Dashed = 300-day average. As of Oct 17, 2026.
Follow Sanifoam Sunger Sanayi ve Ticaret AS in your weekly email
Every Wednesday you see whether Sanifoam Sunger Sanayi ve Ticaret AS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Sanifoam Endustri ve Tuketim Urunleri Sanayi Ticaret A.S., together with its subsidiaries, produces, converts, and supplies industrial and cleaning products in Turkey and internationally.
Show moreShow less
It offers Basotect and Firex foams; Echobon, a high-density ecological insulation material; Echopol, a low-density flexible foam product; SaniFilter material; SaniShine, a high strength flexible polyurethane foam; SaniHydro sponge; SaniFelt, a fibre felt product; SaniSeal, a sealing material; SaniTape, a self-adhesive tape; coating and layering products; and SaniWood, a plywood and compact laminate product.
The company also provides scrubber sponges, cleaning clothes, bath sponges, and scouring fibers, as well as car sponges with shampoo under the Sanitex, Star, and Blues brands; microfiber clothes, stainless steel scourers, and melamine and cellulosic sponges; and polyether and polyester sponges.
In addition, it offers logistics, storage, and distribution services. The company serves the automotive, home appliances, industrial insulation, acoustics, and cleaning sectors. It exports its products. The company was incorporated in 1990 and is headquartered in Tekirdag, Turkey.
Stock analysis
Sanifoam Sunger Sanayi ve Ticaret AS (SANFM) currently trades at 4.18 TRY, while our model-based Fair Value estimate is 0.8200 TRY, 80.4% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 4.51 TRY per share, and 5 of the 14 models we run sit above the 4.18 TRY price.
Bear case: the Earnings-Based group reads lowest at 0.1700 TRY, and 9 of the 14 models stay below the price. Data coverage for this calculation is low.
Quality & growth
The Quality Score stands at 26/100 (below-average quality), in the Consumer Defensive sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Sanifoam Sunger Sanayi ve Ticaret AS reported revenue of 1.2B TRY in FY2025 versus 144M TRY in FY2021, a compound +68.0%/yr. Reported net income was 1.8M TRY in FY2025, compounding −50.8%/yr from FY2021.
Key figures
Market cap 1.6B TRY (≈ $31.7M) · P/E ratio 114.6 · P/S ratio 0.18 · EPS (TTM) −0.0200 TRY · Net margin 0.2% · Return on equity 1.7% · Return on assets (EBIT) 7.8% · Operating margin 11.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 27 out of 100 (medium confidence).
What moves the price
The share trades about 64% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −28% fair-value upside, at −80%, SANFM screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (0.0800 TRY to 6.07 TRY). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear0.8200 TRYFair Value 0.8200 TRYBull0.8200 TRY
Price 4.18 TRY · Upside -80.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+1.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+54.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+60.1%
Start year 2020 (pandemic). Over 10 years: +39.7% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TRY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TRY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−61.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−61.1%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 12%
⚠ Revenue per share shrinking 11.6%/yr over ~6Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Compare Sanifoam Sunger Sanayi ve Ticaret AS with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 238 stocks
Beats the industry median on 1/13 measures
Overall it trails its industry peers.
Valuation
Quality Score26 · Bottom 25%
Fair Value upside−80.4% · Bottom 25%
Profitability
Return on equity (12 months)1.7% · Below median
Return on assets0.1% · Bottom 25%
Net margin (12 months)1.3% · Below median
Operating margin (12 months)11.5% · Above median
Growth and dividend
Revenue growth3.7% · Below median
Dividend yield (12 months)0.0% · Bottom 25%
Balance sheet
Debt / equity0.67× · Highest 25%
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
P/E (12 months)114.6× · Priciest 25%
P/B2.74× · Pricier than median
P/S (12 months)1.28× · Pricier than median
EV/EBITDA26.6× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 25
FUTURE (revenue growth)19· sector 19
PAST (return on equity)7· sector 29
HEALTH (low debt)67· sector 98
DIVIDEND (yield)0· sector 54
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Sanifoam Sunger Sanayi ve Ticaret AS Fair Value". https://www.fairvalue-calculator.com/stock/SANFM
Frequently asked questions
Is Sanifoam Sunger Sanayi ve Ticaret AS (SANFM) overvalued or undervalued?
As of Oct 17, 2026, our model estimates a fair value of 0.8200 TRY versus a price of 4.18 TRY, about −80% upside (overvalued).
What is the fair value of SANFM?
Our model-based fair value for Sanifoam Sunger Sanayi ve Ticaret AS is 0.8200 TRY (as of Oct 17, 2026), built from audited fundamentals. The current price: 4.18 TRY.
What is the quality score of SANFM?
Sanifoam Sunger Sanayi ve Ticaret AS has a Quality Score of 26/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
Our model-based price target is the fair value of 0.8200 TRY (as of Oct 17, 2026) from 14 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Sanifoam Sunger Sanayi ve Ticaret AS stock forecast for 2026?
Our models put fair value at 0.8200 TRY, about −80% upside versus a price of 4.18 TRY (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
Sanifoam Sunger Sanayi ve Ticaret AS reported trailing-twelve-month revenue of about 1.2B TRY (latest available figure, as of Oct 17, 2026).
What is the intrinsic value of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sanifoam Sunger Sanayi ve Ticaret AS it is 0.8200 TRY per share (as of Oct 17, 2026), against a price of 4.18 TRY. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Sanifoam Sunger Sanayi ve Ticaret AS stock overvalued or undervalued in 2026?
As of Oct 17, 2026, SANFM trades above its calculated fair value: price 4.18 TRY, fair value 0.8200 TRY, a gap of about −80% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SANFM?
No. The price is what the market pays today (4.18 TRY); the fair value is what the company's own numbers justify (0.8200 TRY). For Sanifoam Sunger Sanayi ve Ticaret AS the two are 3.36 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Sanifoam Sunger Sanayi ve Ticaret AS worth?
The market values Sanifoam Sunger Sanayi ve Ticaret AS at about 1.6B TRY (market capitalisation, as of Oct 17, 2026). Per share that is 4.18 TRY; our models calculate a fair value of 0.8200 TRY per share.
What is the P/E ratio of SANFM?
Sanifoam Sunger Sanayi ve Ticaret AS trades at a price-to-earnings ratio of 114.6 (as of Oct 17, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.8200 TRY is built from several models across several years. Other multiples: P/B 2.7, P/S 1.3, EV/EBITDA 26.6.
How solid is the balance sheet of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
Balance-sheet figures for Sanifoam Sunger Sanayi ve Ticaret AS (as of Oct 17, 2026): return on equity 1.7%, debt of 0.67 per unit of equity. They feed the Quality Score of 26/100, which measures business quality independently of the share price.
How far is SANFM from its 52-week high?
Sanifoam Sunger Sanayi ve Ticaret AS trades at 4.18 TRY, about 64% below its 52-week high of 11.54 TRY and 9% above the low of 3.85 TRY (as of Oct 16, 2026). Distance from the high says nothing about value: that is what the fair value of 0.8200 TRY is for.
Which stocks are comparable to Sanifoam Sunger Sanayi ve Ticaret AS?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, The Estée Lauder Companies Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sanifoam Sunger Sanayi ve Ticaret AS stock attractive at the current price?
The data as of Oct 17, 2026: price 4.18 TRY, calculated fair value 0.8200 TRY (−80%), Quality Score 26/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SANFM calculated?
We run Sanifoam Sunger Sanayi ve Ticaret AS through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.8200 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.4 % above its aggregate fair value. Sanifoam Sunger Sanayi ve Ticaret AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
The closing price on Oct 16, 2026 was 4.18 TRY. Our model-based fair value is 0.8200 TRY, about −80% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sanifoam Sunger Sanayi ve Ticaret AS right now?
The price sits above even our optimistic bull case (0.8200 TRY). The favourable scenario is already priced in. Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Sanifoam Sunger Sanayi ve Ticaret AS
How large is the market capitalisation of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
The market capitalisation of Sanifoam Sunger Sanayi ve Ticaret AS is 1.6B TRY (≈ $31.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
The price-to-sales ratio of Sanifoam Sunger Sanayi ve Ticaret AS is 0.18 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
Earnings per share at Sanifoam Sunger Sanayi ve Ticaret AS are −0.0200 TRY (price ÷ EPS = P/E 114.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
The net margin of Sanifoam Sunger Sanayi ve Ticaret AS is 0.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
The return on equity (ROE) of Sanifoam Sunger Sanayi ve Ticaret AS is 1.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
On an EBIT basis the return on assets of Sanifoam Sunger Sanayi ve Ticaret AS is 7.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
The operating margin of Sanifoam Sunger Sanayi ve Ticaret AS is 11.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
Revenue at Sanifoam Sunger Sanayi ve Ticaret AS is growing +3.7% versus a year earlier (3y avg +54.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sanifoam Sunger Sanayi ve Ticaret AS (SANFM)?
Earnings per share at Sanifoam Sunger Sanayi ve Ticaret AS are growing −43.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Sanifoam Sunger Sanayi ve Ticaret AS (SANFM) generate?
The free cash flow of Sanifoam Sunger Sanayi ve Ticaret AS is −256M TRY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Sanifoam Sunger Sanayi ve Ticaret AS (SANFM) carry?
The net debt of Sanifoam Sunger Sanayi ve Ticaret AS is 370M TRY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Sanifoam Sunger Sanayi ve Ticaret AS in the live analysis
One click puts Sanifoam Sunger Sanayi ve Ticaret AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
Thin data
Oct 17, 2026